AAAAAA
Results: 51-75/80
Authors:
Ryden, L
Remme, WJ
Citation: L. Ryden et Wj. Remme, Treatment of congestive heart failure - Has the time come for decreased complexity?, EUR HEART J, 20(12), 1999, pp. 867-871
Authors:
Solang, L
Malmberg, K
Ryden, L
Citation: L. Solang et al., Diabetes mellitus and congestive heart failure - Further knowledge needed, EUR HEART J, 20(11), 1999, pp. 789-795
Authors:
Wood, D
de Backer, G
Graham, I
Mancia, G
Pyorala, K
Ryden, L
Faergeman, O
van Zwieten, P
Citation: D. Wood et al., Coronary heart disease prevention task force - Reply, EUR HEART J, 20(11), 1999, pp. 843-844
Authors:
Ryden, L
Fox, KM
Citation: L. Ryden et Km. Fox, Reuse of devices in cardiology, EUR HEART J, 20(10), 1999, pp. 709-710
Authors:
Shimizu, M
Wang, QD
Sjoquist, PO
Ryden, L
Citation: M. Shimizu et al., Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT(1)-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs, J CARDIO PH, 34(4), 1999, pp. 512-517
Authors:
Shimizu, M
Wang, QD
Sjoquist, PO
Ryden, L
Citation: M. Shimizu et al., The angiotensin II AT(1)-receptor antagonist candesartan improves functional recovery and reduces the no-reflow area in reperfused ischemic rat hearts, J CARDIO PH, 34(1), 1999, pp. 78-81
Authors:
Norhammar, AM
Ryden, L
Malmberg, K
Citation: Am. Norhammar et al., Admission plasma glucose - Independent risk factor for long-term prognosisafter myocardial infarction even in nondiabetic patients, DIABET CARE, 22(11), 1999, pp. 1827-1831
Authors:
Stahle, A
Nordlander, R
Ryden, L
Mattsson, E
Citation: A. Stahle et al., Effects of organized aerobic group training in elderly patients dischargedafter an acute coronary syndrome. A randomized controlled study, SC J RE MED, 31(2), 1999, pp. 101-107
Authors:
Ryden, L
Citation: L. Ryden, Strategies for sustainable development - experiences from a university cooperation in the Baltic Sea region. (vol 70, pg 2263, 1998), PUR A CHEM, 71(6), 1999, pp. AR1
Authors:
Lisspers, J
Sundin, O
Hofman-Bang, C
Nordlander, R
Nygren, A
Ryden, L
Ohman, A
Citation: J. Lisspers et al., Behavioral effects of a comprehensive, multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: A prospective, randomized, controlled study, J PSYCHOSOM, 46(2), 1999, pp. 143-154
Authors:
Segawa, D
Sjoquist, PO
Nordlander, M
Wang, QD
Gonon, A
Ryden, L
Citation: D. Segawa et al., Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridine, EUR J PHARM, 380(2-3), 1999, pp. 123-128
Authors:
Malmberg, K
Norhammar, A
Wedel, H
Ryden, L
Citation: K. Malmberg et al., Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction - Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study, CIRCULATION, 99(20), 1999, pp. 2626-2632
Authors:
Packer, M
Poole-Wilson, PA
Armstrong, PW
Cleland, JGF
Horowitz, JD
Massie, BM
Ryden, L
Thygesen, K
Uretsky, BF
Citation: M. Packer et al., Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure, CIRCULATION, 100(23), 1999, pp. 2312-2318
Authors:
Linde, C
Gadler, F
Kappenberger, L
Ryden, L
Citation: C. Linde et al., Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy, AM J CARD, 83(6), 1999, pp. 903-907
Authors:
Gadler, F
Linde, C
Ryden, L
Citation: F. Gadler et al., Rapid return of left ventricular outflow tract obstruction and symptoms following cessation of long-term atrioventricular synchronous pacing for obstructive hypertrophic cardiomyopathy, AM J CARD, 83(4), 1999, pp. 553-557
Authors:
Sutton, R
Ryden, L
Bourgeois, I
Citation: R. Sutton et al., The foundations of cardiac pacing part II An illustrated guide to rate variable pacing - Introduction, BAKKEN RES, 1, 1999, pp. 1-1
Authors:
Sutton, R
Ryden, L
Bourgeois, I
Citation: R. Sutton et al., Cardiodynamics, BAKKEN RES, 1, 1999, pp. 3-32
Authors:
Sutton, R
Ryden, L
Bourgeois, I
Citation: R. Sutton et al., Hemodynamic impact of bradyarrhythmias and the effects of rate variable pacing, BAKKEN RES, 1, 1999, pp. 33-43
Authors:
Sutton, R
Ryden, L
Bourgeois, I
Citation: R. Sutton et al., Dual chamber pacemakers - How they work, BAKKEN RES, 1, 1999, pp. 45-109
Authors:
Sutton, R
Ryden, L
Bourgeois, I
Citation: R. Sutton et al., Sensor controlled pacemakers - How they work, BAKKEN RES, 1, 1999, pp. 111-153
Authors:
Hedman, A
Linde, C
Nordlander, R
Ryden, L
Sutton, R
Bourgeois, I
Citation: A. Hedman et al., Clinical results of rate variable pacing, BAKKEN RES, 1, 1999, pp. 171-195
Authors:
Ryden, L
Sutton, R
Bourgeois, I
Citation: L. Ryden et al., Activity sensing pacemakers, BAKKEN RES, 1, 1999, pp. 231-240
Authors:
Sutton, R
Ryden, L
Bourgeois, I
Citation: R. Sutton et al., Clinical experience with DDI pacing, BAKKEN RES, 1, 1999, pp. 361-368
Authors:
Sutton, R
Ryden, L
Bourgeois, I
Citation: R. Sutton et al., Pacing for carotid sinus and vasovagal syndromes, BAKKEN RES, 1, 1999, pp. 369-381
Authors:
Sutton, R
Bourgeois, I
Ryden, L
Citation: R. Sutton et al., Indications for pacing, mode selection, programming of rate variable devices, and complications, BAKKEN RES, 1, 1999, pp. 401-421